Literature DB >> 10529833

HIV-(1/2) indeterminate western blot results: follow-up of asymptomatic blood donors in belo horizonte, minas gerais, brazil

.   

Abstract

The clinical and public health importance of indeterminate results in HIV-(1/2) testing is still difficult to evaluate in volunteer blood donors. At Fundacao Hemominas, HIV-(1/2) ELISA is used as the screening test and, if reactive, is followed by Western blot (WB). We have evaluated 84 blood donors who had repeatedly reactive ELISA tests for HIV-(1/2), but indeterminate WB results. Sixteen of the 84 donors (19.0%) had history of sexually transmitted diseases; 18/84 (21.4%) informed receiving or paying for sex; 3/84 (3.6%) had homosexual contact; 2/26 women (7.6%) had past history of multiple illegal abortions and 3/84 (3.6%) had been previously transfused. Four out of 62 donors (6.5%) had positive anti-nuclear factor (Hep2), with titles up to 1:640. Parasitological examination of the stool revealed eggs of S. mansoni in 4/62 (6.4%) donors and other parasites in 8/62 (12.9%). Five (5.9%) of the subjects presented overt seroconversion for HIV-(1/2), 43/84 (51.2%) had negative results on the last visit, while 36/84 (42.9%) remained WB indeterminate. Although some conditions could be found associated with the HIV-(1/2) indeterminate WB results and many donors had past of risky behavior, the significance of the majority of the results remains to be determined.

Entities:  

Year:  1999        PMID: 10529833     DOI: 10.1590/s0036-46651999000300004

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  3 in total

Review 1.  Frequency, causes, and new challenges of indeterminate results in Western blot confirmatory testing for antibodies to human immunodeficiency virus.

Authors:  Ming Guan
Journal:  Clin Vaccine Immunol       Date:  2007-04-04

2.  Prevalence of HIV Indeterminate Western Blot Tests and Follow-up of HIV Antibody Sero-Conversion in Southeastern China.

Authors:  Shouli Wu; Min Gao; Jian Zheng; Pingping Yan; Wei Wang; Xiaoli Lu; Yuefeng Qiu; Yansheng Yan
Journal:  Virol Sin       Date:  2019-06-12       Impact factor: 4.327

3.  HIV serologically indeterminate individuals: Future HIV status and risk factors.

Authors:  George Mwinnyaa; Mary K Grabowski; Ronald H Gray; Maria Wawer; Larry W Chang; Joseph Ssekasanvu; Joseph Kagaayi; Godfrey Kigozi; Sarah Kalibbala; Ronald M Galiwango; Anthony Ndyanabo; David Serwadda; Thomas C Quinn; Steven J Reynolds; Oliver Laeyendecker
Journal:  PLoS One       Date:  2020-08-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.